WPP bid for Grey trumps the competition

Share this article:

Grey shareholders were being offered $1,005 per share under the deal. The agreement, which will allow Grey to operate under its own name, calls for 50 percent of Grey shares to be exchanged for cash and 50 percent of Grey shares to be exchanged for American Depository Shares of WPP.

Grey chairman and chief executive Ed Meyer reportedly will continue with the agency for two more years, according to a report in The New York Times.

In addition to its roster of blue-chip consumers clients, including Procter & Gamble, 3M, Mars and Warner Bros., Grey also operates the full-service medical agency Grey Healthcare Group.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in News

Email Newsletters

More in News

New lipid agents are high on potency, low on doc awareness

New lipid agents are high on potency, low ...

The new PCSK9 class of cholesterol-lowering antibodies continues to look promising, but many doctors—particularly PCPs—have never even heard of the experimental drugs.

Novartis may have game-changing drug

Novartis may have game-changing drug

Key opinion leaders indicate they are ready to embrace Novartis's experimental heart failure medication LCZ696. Such a move could upend heart failure treatment protocols.

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...